The largest database of trusted experimental protocols

Bio majesty jca bm 6050

Manufactured by JEOL
Sourced in Japan

The Bio Majesty JCA-BM 6050 is a clinical chemistry analyzer designed for automated biochemical analysis. It offers high-speed and accurate measurement of a wide range of clinical parameters, including enzymes, proteins, lipids, and metabolites. The analyzer employs proven wet chemistry technology and is capable of processing a large number of samples efficiently.

Automatically generated - may contain errors

7 protocols using bio majesty jca bm 6050

1

Fasting Impact on Bovine Metabolism

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six nonpregnant, nonlactating Holstein cows were enrolled in the study. The average age of cows was 4.7 yr, and average body weight (BW) and body condition score [14 (link)] were 735 kg and 3.5, respectively. Cows were maintained in individual tie stalls.
Before 48 h fasting, cows were fed a constant amount of grass hay (about 1.0% of BW/d, DM basis) twice daily (0930 and 1630). Animals had free access to water and a trace mineralized salt block throughout the experimental period.
Blood samples were collected from the tail veins at d 0 (before fasting, 0900 h) and d 2 (after 48 h fasting). After sampling, blood samples (heparin tube) were immediately cooled on crushed ice. After centrifugation (1,000×g for 20 min at 4°C), separated plasma was immediately frozen and stored at −30°C until analyses. Plasma concentrations of NEFA, β-hydroxybutyric acid (BHBA), and glucose were determined using a clinical biochemistry autoanalyzer (BioMajesty JCA-BM 6050; JEOL Ltd., Tokyo, Japan).
Liver biopsies were performed at d 0 (before fasting) and d 2 (after 48 h fasting), following a procedure described previously [15 (link)]. Liver samples were rinsed with ice-cold saline solution and immediately frozen in liquid nitrogen. Samples were stored at −80°C until gene and protein expression analyses.
+ Open protocol
+ Expand
2

Serum and Liver Lipid Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was collected from the mice, incubated at 25 °C for 30 min and at 4 °C for 16 h, centrifuged at 1,000 × g for 30 min at 4 °C and the serum collected and stored at −80 °C until use. Biochemical blood tests were conducted with an automated analyser (Bio Majesty JCA-BM6050; JEOL, Tokyo, Japan). TG levels in the liver were quantified by colorimetric assay using the Triglyceride Quantification Assay kit according to the manufacturer’s protocol.
+ Open protocol
+ Expand
3

Blood Biomarkers and Kidney Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood examinations were conducted using a Bio Majesty JCA-BM 6050 (JEOL, Tokyo, Japan). All blood samples were drawn in the morning after the subjects had completed an overnight fast for the measurement of glycated hemoglobin (HbA1c), total cholesterol, triglycerides, and Cr.
Hypertension was defined as systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, and/or having received treatment for hypertension. Dyslipidemia was considered when total cholesterol concentration >5.69 mmol/L, triglycerides concentration >1.70 mmol/L, and/or when patients received treatment for dyslipidemia.
The eGFR was calculated as follows17 (link) : male: eGFR (mL/min/1.73 m2)=194×age–0.287×(serum Cr)–1.094; and female: eGFR=194×age–0.287×(serum Cr)–1.094×0.739.
+ Open protocol
+ Expand
4

Biomarker Measurement Protocol for Clinical Assessments

Check if the same lab product or an alternative is used in the 5 most similar protocols
The serum concentrations of ANGPTL2 were determined using an ANGPTL2 enzyme-linked immunosorbent assay kit (Immuno-Biological Laboratories, Co., Ltd., Gunma, Japan). Serum concentrations of C-reactive protein (CRP) were determined by latex agglutination using BM6050 (Kyowa-Medex Co., Ltd., Tokyo, Japan) according to the manufacturer's instructions. Concentrations of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) in serum were determined by an electro-chemiluminescence immunoassay using LUMIPULSE G1200® (Fujirebio, Inc., Tokyo, Japan) according to the manufacturer's instructions. White blood cell count (WBC), red blood cell count (RBC), and hemoglobin (Hb) were measured using an XE-5000 Hematology Analyzer (Sysmex, Co., Hyogo, Japan) according to the manufacturer's instructions. Hemoglobin A1c (HbA1c) was measured using a BioMajesty® JCA-BM6010 (JEOL Ltd., Tokyo, Japan) according to the manufacturer's instructions. Blood sugar (BS), serum total cholesterol (TC), triglyceride (TG), creatinine (Cr), uric acid (UA), and serum amylase (AMY) levels were measured using a BioMajesty® JCA-BM6050 (JEOL Ltd.) according to the manufacturer's instructions.
+ Open protocol
+ Expand
5

Comprehensive Metabolic Profiling of Fasted Subjects

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were drawn in the morning after an overnight fast for measurement of blood count (including neutrophil and lymphocytes), glycated hemoglobin (HbA1c), total cholesterol (TC), triglycerides (TG), uric acid (UA) and creatinine. Complete blood count and examinations were performed using a Beckman Coulter LH 780 instrument and Bio Majesty JCA-BM 6050 (JEOL, Tokyo, Japan).
NLRs were calculated as the ratio of the absolute neutrophil and lymphocyte counts. Total white blood cells (WBCs), neutrophils and lymphocytes, were obtained from the same automated blood sample. Hypertension was defined as systolic blood pressure (SBP) >140 mmHg, diastolic blood pressure (DBP) >90 mmHg, and/or having received treatment for hypertension. Dyslipidemia was defined as a TC concentration >5.69 mmol/L, a TG concentration >1.70 mmol/L, and/or having received treatment for dyslipidemia.
The estimated glomerular filtration rate (eGFR) was used to estimate kidney function and was calculated as follows [26] : Male: eGFR (mL•min -1 •1.73 m -2 ) = 0.741 × 175 × age -0.203 × (serum creatinine) -1.154 . Female: eGFR = 0.741 × 175 × age -0.203 × (serum creatinine) -1.154 × 0.742.
+ Open protocol
+ Expand
6

Biomarker Assessment in Metabolic Disorders

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were drawn in the morning after an overnight fast for measurement of glycated hemoglobin (HbA1c), total cholesterol (TC), triglycerides (TG), and creatinine. Complete blood count and examinations were performed using a Bio Majesty JCA-BM 6050 (JEOL, Tokyo, Japan). Urinary albumin and creatinine concentrations were measured in spot urine collected in the early morning. Urinary albumin was determined by a turbidimetric immunoassay (SRL Laboratories, Tokyo, Japan). Hypertension was defined as systolic blood pressure (SBP) >140 mmHg, diastolic blood pressure (DBP) >90 mmHg, and/or having received treatment for hypertension. Dyslipidemia was defined as TC concentration >5.69 mmol/L, TG concentration >1.70 mmol/L, and/or having received treatment for dyslipidemia.
The estimated glomerular filtration rate (eGFR) was used to estimate kidney function and was calculated as follows [29] :
Male: eGFR (mL•min -1 •1.73 m -2 ) = 0.741 × 175 × age -0.203 × (serum creatinine) -1.154 . Female: eGFR = 0.741 × 175 × age -0.203 × (serum creatinine) -1.154 × 0.742.
+ Open protocol
+ Expand
7

Cardiometabolic Risk Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were drawn in the morning after an overnight fast for measurement of glycated hemoglobin (HbA1c), total cholesterol (TC), triglyceride (TG), uric acid, serum albumin, and creatinine levels.
Complete blood counts and examinations were performed using a Beckman Coulter LH 780 instrument and Bio Majesty JCA-BM 6050 (JEOL, Tokyo, Japan).
Urinary albumin and creatinine concentrations were measured in spot urine collected in the early morning. Urinary albumin was determined by a turbidimetric immunoassay (SRL Laboratories, Tokyo, Japan). The mean UAE value was determined from three urine samples. Hypertension was defined as systolic blood pressure (SBP) >140 mmHg, diastolic blood pressure (DBP) >90 mmHg, and/or having received treatment for hypertension. Dyslipidemia was defined as a TC concentration >5.69 mmol/L, a TG concentration >1.70 mmol/L, and/or having received treatment for dyslipidemia.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!